Liver Metastases and ECF – A Possible Treatment In A Not Good Situation

Liver metastases are uncommon in men with castrate resistant prostate cancer (CRPC). Having liver metastases is associated with more serious disease and shorter survival. How to treat men with liver metastases is still not very clear. It is felt that more active treatment might benefit these men. A standard regimen for treating gastric cancer is Epirubicin, Cisplatin and Flurouracil (ECF). This regimen has been reported to also have a response in CRPC in men with liver metastases. In a research survey of the use of ECF in CRPC was evaluated with the primary objective of determining its anti-tumor activity in [...]